Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pathologist Presence Cuts Down Risk of Breast Cancer Repeat Surgery

By HospiMedica International staff writers
Posted on 14 Mar 2012
The number of repeat breast cancer surgeries can be cut down drastically by having an on-site pathologist in the operating room (OR), who examines the tumors and lymph nodes immediately after removal, according to a new study. More...


Researchers at the University of Michigan Comprehensive Cancer Center (Ann Arbor, USA) examined the impact an intraoperative pathology consultation service had on multiple facets of breast cancer surgery by comparing 271 patients that underwent surgery during the eight month period before the establishment of a pathology laboratory, to 278 patients treated during the eight month period after it was performed routinely, when a pathologist examined the tissues and fed the results back to the waiting operating staff.

The results showed that the average number of surgeries per patient decreased from 1.5 to 1.23, and the number of patients requiring only one surgery increased from 59% to 80%. Reexcision rates decreased from 26% to 9%, with frozen section examinations allowing 93% of node-positive patients to avoid a second surgery for axillary lymph node dissection. In practice, one in every 10 women did not have to undergo a second surgery. A cost analysis showed savings between USD 400-600 per breast cancer patient, even when accounting for fewer axillary lymph node dissections. The study was published early online on December 16, 2011, in the American Journal of Surgery.

“The frequent need for second surgeries among patients undergoing breast cancer surgery represents a tremendous burden for patients,” said lead author associate professor of surgery Michael Sabel, MD. “Beyond the inconvenience and additional time away from work, additional surgeries can result in worse cosmetic outcomes and increased complication rates. Our experience shows that offering on-site pathology consultation has a substantial impact on quality of care.”

Including an on-site pathology lab in the OR requires a different approach for preserving and undertaking cell biopsies, called a frozen section analysis. Once completed, the pathologists perform standard biopsy tests using traditional methods; results for both types of analyses have proved consistent. To include on-site pathology requires overcoming more obstacles, such as transporting the tissue samples, building a pathology facility, and staffing it appropriately at an offsite surgical center.

Related Links:

University of Michigan Comprehensive Cancer Center



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.